Revenue (Annual)

Revenue: The sum of all revenue fields included for a company's operating activities.

ShockWave Medical, Inc. (SWAV) had Revenue of $730.23M for the most recently reported fiscal year, ending 2023-12-31.

Quarterly Annual

Figures for fiscal year ending 2023-12-31

Income Statement Financials
Revenue	$730.23M
Net Income	$147.28M
Cost of Goods Sold	$95.39M
Gross Profit	$634.84M
Operating Expenses	$571.14M
Operating Income	$159.09M
Non-Operating Income/Expense	$15.19M
Pre-Tax Income	$174.28M
Normalized Pre-Tax Income	$174.28M
Income after Taxes	$147.28M
Income from Continuous Operations	$147.28M
Consolidated Net Income/Loss	$147.28M
Normalized Income after Taxes	$147.28M
EBIT	$159.09M
EBITDA	$170.96M
Weighted-Average Shares Outstanding (Basic)	36.71M
Weighted-Average Shares Outstanding (Diluted)	38.21M
Earnings per Share (EPS) (Basic)	$4.01
Earnings per Share (EPS) (Diluted)	$3.85
Balance Sheet Financials
Current Assets	$1.23B
Property, Plant, and Equipment	$68.92M
Long-Term Assets	$341.30M
Total Assets	$1.57B
Current Liabilities	$104.20M
Long-Term Debt	$731.86M
Long-Term Liabilities	$793.68M
Total Liabilities	$897.89M
Common Equity	$668.68M
Tangible Shareholders Equity	$536.25M
Shareholders Equity	$668.68M
Common Shares Outstanding	36.99M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$196.05M
Cash Flow from Investing Activities	$-625.73M
Cash Flow from Financial Activities	$600.40M
Beginning Cash	$158.30M
End Cash	$329.83M
Increase/Decrease in Cash	$171.52M
Stock-Based Compensation	$73.23M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	11.76
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.52
Debt to Equity Ratio	1.09
Gross Margin	86.94%
Operating Margin	21.79%
EBIT Margin	21.79%
EBITDA Margin	23.41%
Pre-Tax Profit Margin	23.87%
Profit Margin	20.17%
Free Cash Flow	$165.46M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.47
Inventory Turnover	0.89
Receiveable Turnover	6.37
Days Sales in Receivables	57.26
Return on Equity	22.03%
Return on Tangible Equity	27.46%
Return on Assets	9.40%
Return on Investments	10.52%
Book Value Per Share	$18.08
Free Cash Flow per Share	$4.33
Operating Cash Flow per Share	$5.13

Data from Zacks Investment Research, Inc.